- 1-10 Employees
- Based in Melbourne, Australia
AdAlta is the pioneer of a novel technology platform that mimics the shape and engineers key stability features of the antigen binding domain of shark antibodies into human proteins to create unique compounds, known as i-bodies, for therapeutic intervention in disease.
Most Recent Annual Report
2022 Annual Report
Older/Archived Annual Reports